Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Journal of Human Hypertension
|
May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial
Joshua G Kovoor, Clara K Chow, Abdul Salam, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 28, 2007
Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation
Christopher S Stevenson, Cerys Docx, Ruth Webster, et al.
Lancet (London, England)
|
September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily R Atkins, Graham S Hillis, et al.
European Journal of Preventive Cardiology
|
March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease
Vanessa Selak, Chris Bullen, Sandrine Stepien, et al.
JAMA Cardiology
|
April 13, 2022
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial
Sonali R Gnanenthiran, Nelson Wang, Gian Luca Di Tanna, et al.
Global Heart
|
September 2, 2025
WHF Roadmap on Single Pill Combination Therapies
Enrico G Ferro, Gautam Satheesh, José Castellano, et al.
BMC Public Health
|
July 26, 2019
Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries
Felix Limbani, Jane Goudge, Rohina Joshi, et al.
Global Heart
|
November 16, 2019
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension Program
Ruth Webster, Gary Parker, Stephane Heritier, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander Bennett, Clara K Chow, Michael Chou, et al.
The Lancet. Global Health
|
September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial
Thomas Lung, Stephen Jan, H Asita de Silva, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Journal of Human Hypertension
|
May 14, 2024
Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial
Joshua G Kovoor, Clara K Chow, Abdul Salam, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
August 28, 2007
Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation
Christopher S Stevenson, Cerys Docx, Ruth Webster, et al.
Lancet (London, England)
|
September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily R Atkins, Graham S Hillis, et al.
European Journal of Preventive Cardiology
|
March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease
Vanessa Selak, Chris Bullen, Sandrine Stepien, et al.
JAMA Cardiology
|
April 13, 2022
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial
Sonali R Gnanenthiran, Nelson Wang, Gian Luca Di Tanna, et al.
Global Heart
|
September 2, 2025
WHF Roadmap on Single Pill Combination Therapies
Enrico G Ferro, Gautam Satheesh, José Castellano, et al.
BMC Public Health
|
July 26, 2019
Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries
Felix Limbani, Jane Goudge, Rohina Joshi, et al.
Global Heart
|
November 16, 2019
Strategic, Successful, and Sustained Synergy: The Global Alliance for Chronic Diseases Hypertension Program
Ruth Webster, Gary Parker, Stephane Heritier, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Alexander Bennett, Clara K Chow, Michael Chou, et al.
The Lancet. Global Health
|
September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial
Thomas Lung, Stephen Jan, H Asita de Silva, et al.
Page
of 9